Beneficial Ownership Report · SCHEDULE 13G
Baird Medical Investment Holdings Ltd
BDMDNASDAQEQUITYCurrent
Beneficial Ownership Report
Structured filing — SCHEDULE 13G
primary_doc.xml
Subject company
- Company
- Baird Medical Investment Holdings Ltd
- Company CIK
- 0001982444
- Street
- Rm 202, 2/F, Baide Bldg, Bldg 11
- Street (continued)
- No.15, Rongtong Street, Yuexiu District
- City
- Guangzhou
- State / country code
- F4
- Postal code
- 000000
Statement details
- Security class
- Ordinary Shares, $0.0001 par value
- Event date
- 09/24/2026
- Rule designation
- Rule 13d-1(c)
Reporting person 1
- Name
- L1 Capital Global Opportunities Master Fund, Ltd.
- Citizenship / organization
- E9
- Reporting person type
- FI
- Aggregate amount owned
- 3,551,868.00
- Percent of class
- 9.99
- Sole voting power
- 3,551,868.00
- Shared voting power
- 0.00
- Sole dispositive power
- 3,551,868.00
- Shared dispositive power
- 0.00
- Aggregate excludes certain shares
- N
Item 1
Issuer
Baird Medical Investment Holdings Ltd
Principal executive office address
Room 202, 2/F, Baide Building, Building 11, No.15, Rongtong Street, Yuexiu District, Guangzhou, Peoples Republic of China
Item 2
Citizenship
Cayman Islands
Filing person
L1 Capital Global Opportunities Master Fund, Ltd.
Principal business or residence address
3rd Floor, Citrus Grove Building, 106 Goring Ave. George Town PO Box 10085 Grand Cayman, Cayman Islands KY1-1001
Item 3
Not applicable indication
Y
Item 4
Percent of class
9.99%
Amount beneficially owned
3,551,868 The amounts in Row (5), (7) and (9) represent 110,070 Ordinary Shares and 3,441,798 Ordinary Shares issuable upon conversion of a Senior 8% Original Issue Discount Convertible Promissory Note, subject to a 9.99% beneficial ownership limitation. The amounts do not include an additional 2,475,826 Ordinary Shares issuable upon conversion of a Senior 8% Original Issue Discount Convertible Promissory Note, subject to a 9.99% beneficial ownership limitation The percentage set forth on Row (11) of the cover page for the Reporting Person is based on 33,612,440 Ordinary Shares outstanding, based on the Issuer's Prospectus Supplement under Rule 424(b)(5), filed with the Securities and Exchange Commission on September 24, 2026. David Feldman and Joel Arber are the Directors of L1 Capital Global Opportunities Master Fund, Ltd. As such, L1 Capital Global Opportunities Master Fund, Ltd., Mr. Feldman, and Mr. Arber may be deemed to beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the issuer's securities described herein. To the extent Mr. Feldman and Mr. Arber are deemed to beneficially own such securities, Mr. Feldman and Mr. Arber disclaim beneficial ownership of these securities for all other purposes.
Sole voting power
3,551,868
Shared voting power
0
Sole dispositive power
3,551,868
Shared dispositive power
0
Item 5
Not applicable indication
Y
Item 6
Not applicable indication
Y
Item 7
Not applicable indication
Y
Item 8
Not applicable indication
Y
Item 9
Not applicable indication
Y
Item 10
Not applicable indication
N
Certifications
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
Signature 1
- Reporting person
- L1 Capital Global Opportunities Master Fund, Ltd.
- Signed
- /s/ David Feldman
- Title
- David Feldman, Director
- Date
- 10/01/2026